StockNews.com upgraded shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Monday. ELV has been the subject of a number of other reports. Jefferies Financial Group raised their price target on shares of Elevance Health from $602.00 to $604.00 and […]